Form D · Pharmaceuticals

Trained Therapeutics Discovery, Inc.

Dallas, TX · CIK 0001811734

Offering snapshot reported Feb 10, 2021 · SEC filing

Reported sold
$6.01M
Offering amount: $6.01M
Investors reported
45
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Jul 11, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.01M$6.01MJun 23, 2020: $5,727,879.00Jun 23, 2020Feb 10, 2021: $6,012,067.00Feb 10, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$5,727,879 → $6,012,067
  • Reported investors44 → 45

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 10, 2021Amendment$6,012,067$284,188vs Jun 23, 202045SEC filing
Jun 23, 2020Initial$5,727,879No comparison44SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-369493

Source: Form D, filed Feb 10, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Leighton Durham Iii Executive, Promoter

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
2223 W. Jefferson Blvd.
Dallas, TX, 75208